Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 14-Feb-2023
No. of pages: 128

The report focuses on the Chronic Obstructive Pulmonary Disease (COPD) Treatment market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Chronic Obstructive Pulmonary Disease (COPD) Treatment market.

Major Players in the Chronic Obstructive Pulmonary Disease (COPD) Treatment market are:

GlaxoSmithKline

Novartis AG

Sunovion Pharmaceuticals

CHIESI Farmaceutici

AstraZeneca

Mylan

Boehringer Ingelheim International GmbH

Teva Pharmaceutical Industries

Orion Corporation

On the basis of types, the Chronic Obstructive Pulmonary Disease (COPD) Treatment market is primarily split into:

Corticosteroids

Phosphodiesterase Type 4 Inhibitors

Bronchodilators

Others

On the basis of applications, the market covers:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Overview
1.1 Product Overview and Scope of Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
1.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Segment by Type
1.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Segment by Application
1.3.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Chronic Obstructive Pulmonary Disease (COPD) Treatment (2017-2029)
1.5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Chronic Obstructive Pulmonary Disease (COPD) Treatment Industry
1.7 Impact of Carbon Neutrality on the Chronic Obstructive Pulmonary Disease (COPD) Treatment Industry

2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Upstream and Downstream Analysis
2.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Chronic Obstructive Pulmonary Disease (COPD) Treatment Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 GlaxoSmithKline
3.1.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Novartis AG
3.2.1 Novartis AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Sunovion Pharmaceuticals
3.3.1 Sunovion Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Performance (2017-2022)
3.3.4 Business Overview
3.4 CHIESI Farmaceutici
3.4.1 CHIESI Farmaceutici Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Performance (2017-2022)
3.4.4 Business Overview
3.5 AstraZeneca
3.5.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Mylan
3.6.1 Mylan Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Boehringer Ingelheim International GmbH
3.7.1 Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Teva Pharmaceutical Industries
3.8.1 Teva Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Orion Corporation
3.9.1 Orion Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Performance (2017-2022)
3.9.4 Business Overview

4 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Landscape by Player
4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales and Share by Player (2017-2022)
4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Market Share by Player (2017-2022)
4.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Average Price by Player (2017-2022)
4.4 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Gross Margin by Player (2017-2022)
4.5 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Competitive Situation and Trends
4.5.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Concentration Rate
4.5.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue, Price Trend by Type
5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales and Market Share by Type (2017-2022)
5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Market Share by Type (2017-2022)
5.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Price by Type (2017-2022)
5.4 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue and Growth Rate of Corticosteroids (2017-2022)
5.4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue and Growth Rate of Phosphodiesterase Type 4 Inhibitors (2017-2022)
5.4.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue and Growth Rate of Bronchodilators (2017-2022)
5.4.4 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue and Growth Rate of Others (2017-2022)

6 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Analysis by Application
6.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Consumption and Market Share by Application (2017-2022)
6.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Consumption and Growth Rate of Hospital Pharmacies (2017-2022)
6.3.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Consumption and Growth Rate of Retail Pharmacies (2017-2022)
6.3.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Consumption and Growth Rate of Online Pharmacies (2017-2022)

7 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales and Revenue Region Wise (2017-2022)
7.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales and Market Share, Region Wise (2017-2022)
7.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Forecast (2022-2029)
8.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue Forecast (2022-2029)
8.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Price and Trend Forecast (2022-2029)
8.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales and Revenue Forecast (2022-2029)
8.2.3 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales and Revenue Forecast (2022-2029)
8.2.5 India Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales and Revenue Forecast (2022-2029)
8.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate of Corticosteroids (2022-2029)
8.3.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate of Phosphodiesterase Type 4 Inhibitors (2022-2029)
8.3.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate of Bronchodilators (2022-2029)
8.3.4 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate of Others (2022-2029)
8.4 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Consumption Forecast by Application (2022-2029)
8.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Consumption Value and Growth Rate of Hospital Pharmacies (2022-2029)
8.4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Consumption Value and Growth Rate of Retail Pharmacies (2022-2029)
8.4.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Consumption Value and Growth Rate of Online Pharmacies (2022-2029)
8.5 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Forecast Under COVID-19

9 Industry Outlook
9.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Drivers Analysis
9.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Restraints and Challenges
9.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Chronic Obstructive Pulmonary Disease (COPD) Treatment Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Chronic Obstructive Pulmonary Disease (COPD) Treatment Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Chronic Obstructive Pulmonary Disease (COPD) Treatment Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Healthcare Workforce Management System Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 86
    Workforce management is an institutional process that maximizes performance levels and competency for an organization. The process includes all The activities needed to maintain a productive workforce, such as field service management, human resource management, performance and training management, data collection, recruiting, budgeting, forecasting, scheduling and analytics. Workforce management provides a common set of performance-based tools and software to support corporate mana......
  • Global Life Science Analytics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Life Science Analytics market size was valued at US$ 23410 million in 2023. With growing demand in downstream market, the Life Science Analytics is forecast to a readjusted size of US$ 47330 million by 2030 with a CAGR of 10.6% during review period. The research report highlights the growth potential of the global Life Science Analytics market. Life Science Analytics are expected to show stable growth in the future market. Ho......
  • Global Patient Engagement Solutions Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Patient Engagement Solutions market size was valued at US$ 14090 million in 2023. With growing demand in downstream market, the Patient Engagement Solutions is forecast to a readjusted size of US$ 53040 million by 2030 with a CAGR of 20.9% during review period. The research report highlights the growth potential of the global Patient Engagement Solutions market. Patient Engagement Solutions are expected to show stable growth ......
  • Global Operating Room Management Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Operating Room Management market size was valued at US$ 4314.6 million in 2023. With growing demand in downstream market, the Operating Room Management is forecast to a readjusted size of US$ 6494.7 million by 2030 with a CAGR of 6.0% during review period. The research report highlights the growth potential of the global Operating Room Management market. Operating Room Management are expected to show stable growth in the futu......
  • Global Healthcare Supply Chain Managements Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Healthcare Supply Chain Managements market size was valued at US$ 2151.2 million in 2023. With growing demand in downstream market, the Healthcare Supply Chain Managements is forecast to a readjusted size of US$ 4098.9 million by 2030 with a CAGR of 9.6% during review period. The research report highlights the growth potential of the global Healthcare Supply Chain Managements market. Healthcare Supply Chain Managements are ex......
  • Global Healthcare Workforce Management System Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Healthcare Workforce Management System market size was valued at US$ 1543.3 million in 2023. With growing demand in downstream market, the Healthcare Workforce Management System is forecast to a readjusted size of US$ 3331.2 million by 2030 with a CAGR of 11.6% during review period. The research report highlights the growth potential of the global Healthcare Workforce Management System market. Healthcare Workforce Management ......
  • Global Behavioral Health Software Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Behavioral Health Software market size was valued at US$ 1641 million in 2023. With growing demand in downstream market, the Behavioral Health Software is forecast to a readjusted size of US$ 3274.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Behavioral Health Software market. Behavioral Health Software are expected to show stable growth in the f......
  • Global Long-term Care Software Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Long-term Care Software market size was valued at US$ 1339.2 million in 2023. With growing demand in downstream market, the Long-term Care Software is forecast to a readjusted size of US$ 3460.2 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Long-term Care Software market. Long-term Care Software are expected to show stable growth in the future mark......
  • Global Healthcare RCM Outsourcing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Healthcare RCM Outsourcing market size was valued at US$ 19580 million in 2023. With growing demand in downstream market, the Healthcare RCM Outsourcing is forecast to a readjusted size of US$ 40390 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Healthcare RCM Outsourcing market. Healthcare RCM Outsourcing are expected to show stable growth in the f......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs